| Literature DB >> 34496129 |
Yueyuan Liao1,2, Chao Chu1,2, Yang Wang1,2, Wenling Zheng1,2, Qiong Ma1,2, Jiawen Hu1,2, Yu Yan1,2, Jun Yang3, Ruihai Yang3, Keke Wang1,2, Yue Yuan4, Chen Chen1,2, Yue Sun1,2, Yuliang Wu1,2, Jianjun Mu1,2.
Abstract
The pulsatile stress in the microcirculation may contribute to development or progression of chronic kidney disease. However, there is no prospective data confirming whether pulsatile stress in early life affect renal function in middle age. The authors performed a longitudinal analysis of 1738 participants aged 6-15 years at baseline, an ongoing Adolescent Prospective Cohort with a follow-up of 30 years. The authors evaluated the association between pulsatile stress in childhood and adult subclinical renal damage (SRD), adjusting for related covariates. Pulsatile stress was calculated as resting heart rate × pulse pressure. Renal function was assessed with estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (uACR). The results showed that pulsatile stress in childhood was associated with adult SRD (Relative Risk, 1.43; p = .032), and the predictive value of combined pulse pressure and heart rate for SRD was higher than either of them alone. The high pulsatile stress in childhood increased the risk of adult SRD in males (RR, 1.92; p = .003), but this association was not found in females (RR, 0.91; p = .729). Further, the participants were categorized into four groups on the basis of pulsatile stress status in childhood and adulthood. Male patients with high pulsatile stress during childhood but normal pulsatile stress as adults still had an increased risk of SRD (RR, 2.04; 95% CI, 1.18-3.54), while female patients did not (RR, 0.96; 95% CI, 0.46-1.99). The study demonstrated that high pulsatile stress in childhood significantly increased the risk of adult SRD, especially in males. Adequate control of pulse pressure and heart rate from childhood, in the long-term, is very important for preventing kidney damage.Entities:
Keywords: adulthood; childhood; cohort study; pulsatile stress; subclinical renal damage
Mesh:
Substances:
Year: 2021 PMID: 34496129 PMCID: PMC8678770 DOI: 10.1111/jch.14360
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738
Demographic and clinical characteristics of the study participants
| Variable | All patients | Male patients | Female patients |
|
|---|---|---|---|---|
| No. of patients | 1738 | 963 (55.4%) | 775 (44.6%) | |
| Childhood | ||||
| Age (years) | 12 (9, 14) | 12 (9, 14) | 12 (9, 14) | .256 |
| Height (cm) | 136.8 (124.0, 148.6) | 135.5 (123.5, 148.0) | 138.4 (124.2, 149.2) | .088 |
| Weight (kg) | 29.5 (23.0, 38.9) | 28.8 (23.0, 37.5) | 30.9 (23.0, 40.0) | .028 |
| BMI (kg/m2) | 15.9 (14.8, 17.7) | 15.8 (14.8, 17.2) | 16.1 (14.7, 18.0) | .030 |
| BMI z‐score | −0.78 (−1.33, −0.25) | −0.82 (−1.42, −0.28) | −0.74 (−1.27, −0.21) | .01 |
| Busts (cm) | 61.5 (57.0, 68.0) | 61.1 (56.0, 67.9) | 61.5 (58.0, 69.0) | .001 |
| Systolic BP (mm Hg) | 102.6 (96.0, 110.0) | 101.3 (95.3, 110.0) | 103.3 (97.0, 110.0) | .017 |
| Diastolic BP (mm Hg) | 64.0 (59.3, 70.7) | 63.3 (59.0, 70.7) | 64.7 (60.0, 70.7) | .022 |
| Pulse Pressure (mm Hg) | 38.0 (32.0, 43.3) | 37.3 (32.0, 43.4) | 38.0 (32.0, 43.3) | .598 |
| Pulsatile stress (aU) | 2936.0 (2470.9, 3469.2) | 2933.6 (2448.0, 3432.0) | 2941.2 (2520.0, 3520.0) | .071 |
| HR (bpm) | 78.0 (72.0, 84.0) | 78.0 (72.0, 84.0) | 80.0 (72.0, 84.0) | .002 |
| Adulthood | ||||
| Age (years) | 42 (39, 44) | 42 (39, 44) | 42 (39, 44) | .256 |
| Height (cm) | 163.2 (156.8, 168.5) | 167.6 (164.0, 171.5) | 156.8 ± 5.6 | <.001 |
| Weight (kg) | 63.3 (55.8, 71.4) | 69.0 ± 9.9 | 56.9 (52.4, 62.9) | <.001 |
| BMI (kg/m2) | 23.9 (21.9, 26.1) | 24.5 ± 3.1 | 23.2 (21.5, 25.2) | <.001 |
| Waist (cm) | 84.5 (78.0, 91.5) | 87.7 ± 9.1 | 80.7 (75.5, 86.7) | <.001 |
| Hips (cm) | 92.3 (89.0, 95.7) | 92.9 ± 5.4 | 91.5 (88.4, 95.2) | <.001 |
| Systolic BP (mm Hg) | 121.3 (112.3, 131.0) | 124.7 (116.3, 133.3) | 116.7 (108.0, 126.7) | <.001 |
| Diastolic BP (mm Hg) | 76.0 (69.0, 84.0) | 78.7 (72.3, 86.3) | 72.7 (65.7, 79.7) | <.001 |
| Pulse Pressure (mm Hg) | 44.7 (40.3, 50.6) | 45.3 (41.0, 51.0) | 44.0 (39.3, 50.0) | .002 |
| Pulsatile stress (aU) | 3268.0 (2859.7, 3797.2) | 3252.7 (2852.0, 3792.0) | 3290.0 (2871.3, 3812.7) | .191 |
| HR (bpm) | 73.0 (67.0, 80.0) | 72.0 (65.0, 78.0) | 75.0 (68.0, 82.0) | <.001 |
| Smoking (%) | 755 (43.4%) | 731 (75.9%) | 24 (3.1%) | <.001 |
| Drinking (%) | 508 (29.2%) | 463 (48.1%) | 45 (5.8%) | <.001 |
| FH.hypertension (%) | 908 (52.2%) | 487 (50.6%) | 421 (54.3%) | .120 |
| FH.diabetes (%) | 278 (16.0%) | 142 (14.7%) | 136 (17.5%) | .113 |
| Fasting glucose (mmol/l) | 4.57 (4.28, 4.91) | 4.59 (4.29, 4.93) | 4.55 (4.26, 4.87) | .049 |
| TC (mmol/l) | 4.49 (4.03, 4.99) | 4.53 (4.04, 5.06) | 4.46 (4.0, 4.91) | .009 |
| HDL‐C (mmol/l) | 1.14 (0.99, 1.33) | 1.07 (0.94, 1.22) | 1.24 (1.08, 1.43) | <.001 |
| LDL‐C (mmol/l) | 2.50 (2.12, 2.89) | 2.56 (2.18, 2.99) | 2.42 (2.05, 2.78) | <.001 |
| Triglycerides (mmol/l) | 1.35 (0.96, 1.94) | 1.52 (1.09, 2.17) | 1.16 (0.85, 1.63) | <.001 |
| Serum uric acid (μmol/L) | 278.8 (225.3, 335.1) | 320.1 (280.7, 369.3) | 227.0 (196.4, 266.6) | <.001 |
| Urine uric acid (μmol/L) | 1309.5 (936.0, 2015.5) | 1357.0 (986.0, 2158.5) | 1264.0 (872.0, 1824.0) | <.001 |
| Serum creatinine (μmol/L) | 75.6 (66.4, 86.0) | 83.4 (75.1, 91.1) | 67.3 (60.5, 73.5) | <.001 |
| Urine albumin (mg/L) | 7.65 (4.10, 13.90) | 8.5 (4.8, 14.3) | 6.4 (3.3, 13.1) | <.001 |
| uACR (mg/mmol) | 0.97 (0.63, 1.73) | 0.88 (0.60, 1.57) | 1.11 (0.69, 1.98) | <.001 |
| eGFR (ml/min per 1.73 m2) | 97.66 (87.21, 111.25) | 96.1 (85.9, 109.7) | 99.7 (89.2, 113.5) | <.001 |
Continuous variables were shown as mean ± SDs if normally distributed or median (quartile 1, quartile 3) if non‐normally distributed. Categorical variables were expressed as numbers and percentages of patients. Statistical analysis was performed by t test when normally distributed; otherwise, the Mann–Whitney U test was used. Differences between groups of categorical variables were compared with chi‐square tests.
Abbreviations: BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate; FH.hypertension, family history of hypertension; FH.diabetes, family history of diabetes; HR, heart rate; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; TC, total cholesterol; uACR, urinary albumin‐to‐creatinine ratio.
FIGURE 1Prevalence of adult subclinical renal damage in normal pulsatile stress group and high pulsatile stress group, overall and by sex group. SRD, subclinical renal damage
FIGURE 2The levels and differences of the eGFR (A) and uACR (B) in normal pulsatile stress group and high pulsatile group, overall and by sex group. eGFR, estimated glomerular filtration rate; uACR, urinary albumin‐to‐creatinine ratio; NPS, normal pulsatile stress group; HPS, high pulsatile stress group
FIGURE 3Relationship between pulsatile stress and eGFR and uACR by correlation analysis. Relationship between pulsatile stress and eGFR in overall patients (A), male patients (B) and female patients (C). Relationship between pulsatile stress and uACR in overall patients (D), male patients (E) and female patients (F). R, correlation coefficient. eGFR, estimated glomerular filtration rate; uACR, urinary albumin‐to‐creatinine ratio
Association of pulsatile stress in childhood and subclinical renal damage in adults, overall and by sex group
| n (%) | RR | 95% CI |
| |
|---|---|---|---|---|
| All patients | 221 (12.7%) | |||
| Model 1 | 1.67 | 1.24–2.26 | .001 | |
| Model 2 | 1.64 | 1.19–2.26 | .003 | |
| Model 3 | 1.43 | 1.03–1.99 | .032 | |
| Male patients | 134 (13.9%) | |||
| Model 1 | 1.99 | 1.35–2.94 | <.001 | |
| Model 2 | 2.10 | 1.38–3.19 | .001 | |
| Model 3 | 1.92 | 1.26–2.94 | .003 | |
| Female patients | 87 (11.2%) | |||
| Model 1 | 1.29 | 0.79–2.11 | .311 | |
| Model 2 | 1.11 | 0.66–1.87 | .700 | |
| Model 3 | 0.91 | 0.52–1.58 | .729 |
Model 1 was unadjusted; Model 2 was adjusted for age, sex (for all patients), body mass index and busts at baseline, body mass index, waist, hips, smoking, drinking, fasting glucose, serum uric acid, triglycerides, total cholesterol, high‐density lipoprotein cholesterol and low‐density lipoprotein cholesterol at follow‐up based on Model 1; Model 3 was adjusted for pulsatile stress at follow‐up based on Model 2. n (%), the number of individuals with SRD (%).
FIGURE 4The receiver operator curve of predictive value of pulsatile stress, pulse pressure and heart rate for subclinical renal damage. HR, heart rate; PS, pulsatile stress; PP, pulse pressure
Relative risks of subclinical renal damage in adults according to pulsatile stress group in childhood and adulthood
| Unadjusted model | Adjusted MODEL | ||||
|---|---|---|---|---|---|
| n (%) | RR (95% CI) |
| RR (95% CI) |
| |
| All patients | |||||
| Group I | 86 (8.5%) | Reference | Reference | ||
| Group II | 59 (20.6%) | 2.79 (1.94, 4.01) | <.001 | 2.32 (1.58, 3.40) | <.001 |
| Group III | 36 (12.1%) | 1.49 (0.98, 2.25) | .060 | 1.53 (0.99, 2.35) | .053 |
| Group IV | 40 (28.4%) | 4.27 (2.78, 6.55) | <.001 | 3.41 (2.16, 5.39) | <.001 |
| Male patients | |||||
| Group I | 52 (9.2%) | Reference | Reference | ||
| Group II | 32 (20.5%) | 2.55 (1.58, 4.13) | <.001 | 2.09 (1.24, 3.52) | .006 |
| Group III | 25 (15.6%) | 1.83 (1.10, 3.06) | .021 | 2.04 (1.18, 3.54) | .011 |
| Group IV | 25 (30.9%) | 4.41 (2.54, 7.66) | <.001 | 3.77 (2.07, 6.89) | <.001 |
| Female patients | |||||
| Group I | 34 (7.6%) | Reference | Reference | ||
| Group II | 27 (20.6%) | 3.15 (1.82, 5.46) | <.001 | 2.68 (1.50, 4.79) | .001 |
| Group III | 11 (8.0%) | 1.06 (0.52, 2.15) | .871 | 0.96 (0.46, 1.99) | .911 |
| Group IV | 15 (25.0%) | 4.05 (2.05, 8.00) | <.001 | 2.99 (1.44, 6.23) | .003 |
Adjusted Model was adjusted for age, sex (for all patients), body mass index and busts at baseline, body mass index, waist, hips, smoking, drinking, fasting glucose, serum uric acid, triglycerides, total cholesterol, high‐density lipoprotein cholesterol and low‐density lipoprotein cholesterol at follow‐up. n (%), the number of individuals with SRD (%).